Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The SP $value is ok...
View:
Post by wildbird1 on Apr 04, 2024 8:08am

The SP $value is ok...

Some people on this board pretend that the SP should already be at .50$ up to $2.00.

It doesn't make sense..TLT is just a very small company on a small exchange,with no real revenue,no money and no FDA approved treatments, as a results the SP is exactly were it should be.
Once TLT get BTD and a large pharma deal the SP will climb to a better value,not before.

As of now,the FDA asking TLT for data clarifications is perfectly normal and is an integral part of the FDA trial process.
As we speak TLT-Ruvidar CR% is at 40%...
Ruvidar 40%CR is 70% more potent than Adstiladrin(24%CR and BTD-approved by the FDA).
Ruvidar 40%CR is 115% more potent than Keytruda (19%CR and FDA approved).
All the above bode very well for TLT-Ruvidar, since Adstiladrin with just 24%CR and a very big immuno-deficient restriction did get the FDA-BTD approval(TLT-Ruvidar has no restrictions and can treat 100% of patients).

As we speak,for the first time since that story started,with the pre-BTD submission,TLT has a big foot inside the FDA,with a treatment 70% more potent than the best treatment already approved by the FDA(BTD-approved Adstiladrin,24%CR).

The delays are annoying,but the above give me a nice and reassuring feeling about my investment in TLT.
But that is just me.
Comment by Donein25 on Apr 04, 2024 10:42am
Bird, I totally agree with you on the science and the future. However, I totally disagree that a 0.115 US SP is "exactly where it should be". The current valuation is suitable for a start up that is still working in pietre dishes and test tubes. We have a Phase II trial that is 2/3s complete with "world class" results and we are currently in discussions with FDA regarding BTD ...more  
Comment by menoalittle on Apr 04, 2024 11:02am
>> None of that is built into the current stock price. 100% correct.  I suspect it's more that the stock is being forced (shorted) down by the greedy vultures wanting/expecting to get a boatload of free warrants after they use the (brand new) shares bought in a PP to (eventually) cover their arses. Frankly, that tactic works many more times than not... however, I do recall ...more  
Comment by Longholder99 on Apr 04, 2024 11:48am
If there's any justice in this world,Perraton and RDW have caught that ball and are prepared to deliver some serious payback. Let them get knee deep then a big halt outta nowhere.  Clean out some accounts.
Comment by charlierock on Apr 04, 2024 12:29pm
TLT stock price may be in the doldrums now on this crappy exchange however the stock price could spike much higher on any substantial headline grabbing news. Just look at a long term chart on Sona or PYR. Both of these companies came crashing back down however. At least if TLT spikes it will be justified with some substance in regards to independently verified data. Hey if it happened to them it ...more  
Comment by Oden6570 on Apr 04, 2024 1:07pm
I am once again on the buy with TLT , little bites for me going fwd however I intend to accumulate weekly going fwd. This price point is to attractive right now with all we know of results to date. I see only upside from this price point. I just turned us green with my small buy ! Perhaps others feel the same and will begin some more accumulation :-)
Comment by riverrrow on Apr 04, 2024 4:44pm
I don't know if there's a pp ongoing or not, but contact Roger or TLT and see if you can get in.  The minimum purchase  might not be as much as you think,  and if they throw in 5 year warrants that would be sweet.   It's too bad the tradeable 5 year warrants are expiring soon.  Who would have thought they'd be out of the money.  GLTA.
Comment by stocksnbonds458 on Apr 04, 2024 2:45pm
To say that a penny stock trading at $0.16 with an average daily volume of less than 100k shares is being shorted by "the vultures" is beyond naive, it's just plain foolish. The stock is trading a pennies because other than we faithful longs, NOBODY ELSE IS INTERESTED!!. Vultures and MM's have bigger fish to fry, and your conspiracies regarding the stock being manipulated is ...more  
Comment by menoalittle on Apr 04, 2024 3:19pm
This post has been removed in accordance with Community Policy
Comment by menoalittle on Apr 04, 2024 3:40pm
me don't know everything, or even necessarily very much...  but me no a little, and that is the fact that YOU are the naive one here, pal. Because I happen to know for a proveable FACT that this stock has been recently shorted. (had to repost this after the polite police showed up... lol.)
Comment by Alamir1111 on Apr 04, 2024 3:46pm
Got me 200 warrants for 1$.very good price
Comment by Alamir1111 on Apr 04, 2024 4:30pm
Nov.2020 sp was low .13c.Today .16 that is a 25% gain  or yearly about 5% gain
Comment by Alamir1111 on Apr 06, 2024 12:15pm
Just made 200% on my warrants
Comment by CAinPlap on Apr 04, 2024 4:28pm
Its not so much shorting. It is the fact that a select few have received the phone call from Management a couple weeks ago of an upcoming raise and are selling shares to free up money to participate and refresh their warrants.
Comment by StevenBirch on Apr 04, 2024 4:49pm
That is correct and to say we are down here because there is no interest is really naive. I don't want to be critical of anyone but there are also people who want to take part in these PPs who are better served by doing so at a lower price. They are funding the company so there should be some reward but it's obvious whenever there is "interest" shown the sellers step away then ...more  
Comment by Alamir1111 on Apr 04, 2024 5:21pm
It makes sense sell your shares at 20 -40% discount,drive your portfolio value down to prchase some useless warrants hoping in 5 years you make it.Genius..Out of 20 so raises how many brought in money?At least you can ask for a autographed picture as a bonus
Comment by menoalittle on Apr 04, 2024 5:04pm
I agree that it has probably been the majority of the selling.  My point was simply that there has been some degree of shorting happening.  How much so is rather difficult to figure. 
Comment by Alamir1111 on Apr 04, 2024 9:30pm
TLTFF - Short Volume Report  (REGSHO) All RegSho Dated reported by: FINRA Regular VolumeShort VolumeMar 06Mar 08Mar 12Mar 14Mar 18Mar 20Mar 22Mar 26Mar 28Apr 02Mar 07Mar 11Mar 13Mar 15Mar 19Mar 21Mar 25Mar 27Apr 01Apr 030200,000400,000600,000800,000Highcharts.comMar 21Regular Volume: 48,204Short Volume: 42,204 Historical ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250